Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Telehealth providers in Maryland

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

Telehealth prescribing is allowed in Maryland, including asynchronous care. What Maryland requires of telehealth prescribers and pharmacies, plus listings with their verification status.

Maryland at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Telehealth providers serving Maryland

Bodybuilding Peptides

Sponsored

Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.

Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Maryland (not yet confirmed)

  • Prescription only, no research-use-only sales
  • Public cancellation and refund policy

We may earn a commission from these links.

Telehealth prescribing rules in Maryland

Health Occupations Article sections 1-1001 through 1-1006, added in 2020 (Chapter 15, House Bill 448), govern telehealth by licensed health care practitioners. Telehealth includes both synchronous and asynchronous interactions, and an asynchronous telehealth interaction is an exchange of information that does not occur in real time, including the secure transmission of medical information, clinical data, images, lab results, and self-reported medical history. Section 1-1002 lets a practitioner establish a practitioner-patient relationship through either a synchronous or an asynchronous telehealth interaction after verifying the patient's identity, disclosing the practitioner's name, contact information, and license type, and obtaining consent. Section 1-1003 requires a clinical evaluation appropriate for the patient and condition before treating or prescribing through telehealth and states that the evaluation may be synchronous or asynchronous; telehealth care is held to the in-person standard. The in-person assessment limit in section 1-1003 applies only to Schedule II opiates prescribed for pain. The Maryland Board of Physicians rules (COMAR 10.32.05, amended effective September 15, 2025) repeat these standards, require a Maryland license, and bar treating or prescribing based solely on a static online questionnaire. Care delivered solely by audio-only calls, e-mail, or fax is not telehealth. The peptides in this database are not controlled substances. This record classifies asynchronous prescribing as allowed because the statute expressly permits an asynchronous interaction both to establish the relationship and to perform the required clinical evaluation; a static questionnaire alone is not enough. [2] [3] [4] [5] [6]

Compounded GLP-1 access in Maryland

Maryland law lets the required clinical evaluation be asynchronous (Health Occupations 1-1003). An app-based GLP-1 program can meet the prescribing rules only if a Maryland-licensed practitioner verifies the patient's identity, discloses the practitioner's name, contact information, and license type, obtains consent, and does not rely on a static online questionnaire alone (Health Occupations 1-1002; COMAR 10.32.05). The dispensing pharmacy must still hold a Maryland pharmacy or nonresident pharmacy permit. [3] [4] [5] [7] [13]

Research use only sellers in Maryland

Maryland's Food, Drug, and Cosmetic Act (Health-General Article, Title 21) prohibits selling adulterated or misbranded drugs, and Health Occupations Title 12 limits dispensing of prescription drugs to permitted pharmacies and authorized practitioners. [1] [11] [14]

How to check a telehealth provider in Maryland

  1. Confirm the prescriber is licensed or registered to treat patients located in Maryland; the telehealth rules above explain what Maryland requires. [2] [3] [4] [5] [6]
  2. Ask which pharmacy will fill the prescription and check it in the Maryland Board of Pharmacy (Maryland Department of Health) license lookup. [1] [7] [8] [9] [10] [12]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Maryland. [1] [11] [14]

Common questions in Maryland

Can I get a GLP-1 prescription in Maryland from an online questionnaire or app?

From an app, yes in principle. From a static questionnaire alone, no. Health Occupations sections 1-1002 and 1-1003 let a Maryland-licensed practitioner establish the relationship and perform the required clinical evaluation through an asynchronous telehealth interaction, and the care must meet the in-person standard. The Board of Physicians rule (COMAR 10.32.05.06) bars treating or prescribing based solely on a static online questionnaire. The prescriber still decides whether the information is enough to prescribe safely. [2] [3] [4] [5]

Does a telehealth prescriber need a Maryland license?

Yes. Maryland's telehealth statute applies to practitioners licensed in Maryland, and the Board of Physicians' telehealth regulations in COMAR 10.32.05 require Maryland licensure to treat a patient located in Maryland. [2] [5]

Can an out-of-state pharmacy ship compounded peptides to me in Maryland?

Only if it holds a Maryland nonresident pharmacy permit. Under Health Occupations section 12-403, the pharmacy must submit its latest home-state inspection report and name a Maryland agent for service of process, and a pharmacy that ships compounded sterile preparations such as injectable peptides must also file a USP chapter 797 inspection report from an inspection done within 90 days before its application. Search the Board of Pharmacy license verification before ordering. [1] [7]

All peptide legal questions for Maryland

Sources

  1. [1]Maryland Board of Pharmacy
  2. [2]Maryland Code, Health Occupations section 1-1001, Telehealth definitions
  3. [3]Maryland Code, Health Occupations section 1-1002, Establishing a practitioner-patient relationship through telehealth
  4. [4]Maryland Code, Health Occupations section 1-1003, Telehealth clinical evaluation and prescribing
  5. [5]COMAR 10.32.05, Telehealth (Maryland Board of Physicians), current text as amended effective September 15, 2025 and January 19, 2026
  6. [6]Maryland House Bill 448 (2020), Chapter 15: Health Care Practitioners, Telehealth and Shortage (adds Health Occupations 1-1001 through 1-1006)
  7. [7]Maryland Code, Health Occupations section 12-403, Required standards (including nonresident pharmacies)
  8. [8]COMAR Title 10, Subtitle 34, Board of Pharmacy regulations
  9. [9]COMAR 10.34.37.04, Requirements for nonresident pharmacy operations
  10. [10]Maryland Senate Bill 69 (2015), Chapter 5: repeal of the sterile compounding permit requirement